Free Access
Dairy Sci. Technol.
Volume 90, Number 5, September–October 2010
Page(s) 579 - 588
Published online 07 April 2010

© INRA, EDP Sciences, 2010


The consumption of dairy-based foods may play an important role in the transmission of various food-borne diseases. Among those diseases is brucellosis, which is considered by the Food and Agriculture Organization (FAO), the World Health Organization (WHO) and the Office International des Epizooties (OIE), as one of the most widespread zoonotic diseases of domestic and wild animals throughout the world [21, 23]. Brucellosis is a “re-emerging” disease leading to substantial economic loss as well as considerable human morbidity [21]. It is a disease caused by several species of the genus Brucella [25].

Based on host preferences and pathogenicity, the genus Brucella has been divided into six species: B. melitensis, B. abortus, B. suis, B. canis, B. ovis and B. neotomae. Out of these six species, only B. melitensis and B. abortus are the major pathogenic species in human beings and animals. B. melitensis is typically pathogenic in goats and sheep, while B. abortus is pathogenic in cattle [25]. Brucellosis can be transmitted to human beings by direct contact with materials contaminated with the organism, consumption of unpasteurized milk and milk products, and inhalation of infectious aerosols, especially by workers in abattoirs and microbiology laboratories [22, 25]. The most common signs and symptoms of this disease are undulant fever, weakness, chills, headache, depression and weight loss which can persist from days to years [23].

Traditionally, bacterial isolation and biochemical identification of most pathogenic organisms are slow, laborious and insensitive. Therefore, molecular genetic techniques have recently been involved in studies regarding taxonomy and evolution of bacteria. One of these powerful techniques is PCR, which has become a promising tool for the identification and characterization of bacteria such as Brucella to genus and species level in food products such as milk and cheese [3, 4, 16].

Contaminated and unpasteurized dairy products have been responsible for outbreaks of many food-borne diseases [6]. In Lebanon, dairy products made of unpasteurized milk are usually consumed raw by a large group of the population on a daily basis. While some of those products are prepared in dairy plants, many are still homemade. Dairy food production in Lebanon mostly occurs in its northeastern part, mainly in the Bekaa Valley.

In the last five years, there has been a noticeable increase in the number of food-borne diseases in Lebanon where about 657 cases were attributed to food-borne illnesses in 2005 [9]. This reported increase has highlighted the need to implement control measures in the food industry and the importance of studies that evaluate the microbiological quality of foods. Considering the marked importance of Brucella as a food-borne pathogen, this study aims at isolating and characterizing at the molecular level the different strains of Brucella present in dairy products which are consumed raw in Lebanon. The study also evaluates the antimicrobial resistance patterns of B. abortus to eight different commonly used antimicrobials. The foods included in this study are Baladi cheese (Lebanese cheese balls), Shankleesh (a mold-ripened cheese) and Kishk (a dried fermented milk-wheat mixture).


2.1. Sample collection

A total of 164 samples of Baladi cheese (n = 45), Shankleesh (n = 36) and Kishk (n = 83) were collected from the Bekaa Valley in four field visits conducted from August till December 2004. Samples were obtained from different sources (such as markets, houses and small family dairy farms), packaged in sterile bags, numbered and brought to the laboratory on ice in an ice chest. All samples were analyzed within a maximum of 24 h after their arrival to the laboratory [20].

Samples were collected from different communes, which were divided into four categories based on their number of inhabitants, with samples collected from 20% to 100% of the communes in each category (Tab. I). Most of the samples taken from the small communes were homemade. The original plan was to collect around 250 samples, noting that the number of samples collected in each commune should be roughly proportional to the size of the commune. However, many of the small communes selected for study could not be visited because of bad weather conditions which made access to some roads impossible. In addition, homemade dairy products were not made on a daily basis and sometimes not during our collection trip, which decreases the total number of samples collected to 164 samples divided into 83 Kishk samples, 45 Baladi cheese samples and 36 Shankleesh samples.

Table I.

Number of selected communes according to population size and the number of samples that should be collected in each trip.

2.2. Bacterial isolation and/or enumeration

The bacteria examined in the dairy-based food products included indicator bacteria (aerobic plate count and total coliforms) which were published in a previous study by our group [20] and pathogenic Brucella organisms. For the detection, enrichment and plating of Brucella colonies, a selective medium Brucella Agar (Difco, Paris, France) was used [18]. Bacterial isolation, enumeration and analyses were done according to Harakeh et al. [13], with the exception that all plated cultures were incubated at 37 °C for 48–72 h [8, 14, 15, 19].

It is worth noting that one of the Brucella species, B. abortus, requires microaerophilic conditions of 5–10% CO2 for enhanced growth. Thus, plates were divided into two sets, incubated either under aerobic conditions or in a microaerophilic environment containing 5–10% CO2 conditions [1, 18]. Colonies that exhibited Brucella morphology were counted and preserved for further analyses.

2.3. Biochemical identification of the suspected Brucella species

Suspected Brucella colonies that are characterized by punctate, raised, circular, translucent and white mucoid opaque appearance were first identified by Gram staining [1]. For further confirmation, Gram-negative coccobacilli were simultaneously subjected to oxidase (Kovac’s modification) and urea hydrolysis (Christensen’s method) tests [5].

2.4. DNA extraction

Using a sterile loop, a bacterial colony was suspended in 5 mL of sterile Brain Heart Infusion (BHI) broth (Oxoid, Hampshire, UK). This suspension was incubated overnight using a shaking water bath at 37 °C until a 0.5 McFarland turbidity standard was reached. DNA extraction was conducted using 1 mL of the bacterial suspension to extract total genomic DNA according to the GFX genomic blood DNA Purification Kit from Amersham Biosciences (Little Chalfont, Buckinghamshire, UK) [13].

2.5. Primers used

For the genus-specific identification of Brucella, standard PCR was used where extracted DNA of the suspected Brucella isolates was amplified using the primer pair BRU-UP/BRU-LOW. This primer pair targets a 443 base pair (bp) fragment of the BCSP-31 gene, encoding for an antigen localized on or near the bacterial cell surface of Brucella species [23]. Then, real-time PCR was used to distinguish among the different Brucella species. The forward primer used was obtained from the insertion element IS711, whereas the reverse primers were derived from species-specific chromosomal loci [19]. The former generates a 113 bp PCR product with B. abortus reverse primer, a 252 bp PCR product with B. melitensis reverse primer and 170 bp PCR products with B. suis reverse primer. To generate the fluorescence signal, a double-stranded DNA intercalating dye, SYBR Green I, was used [19].

Finally, the primer pair (1 and 2) was used to determine whether the B. abortus isolates were derived from RB51 vaccine or field strains as stated in Vemulapalli et al. [24]. If the B. abortus isolates were RB51 vaccine strains, then the PCR product would amplify a 1300 bp band indicating that the wboA gene is interrupted by an IS711 element. However, a 400 bp fragment would be produced from all other Brucella species and strains, revealing that the wboA gene remained intact [24].

2.6. PCRs

Standard PCR was performed in a total volume of 25 μL reaction mixture containing: 1.25 μL of each primer (10 pmol·μL−1), 3 μL of 50 ng·μL−1 of the purified DNA template, 2.5 μL of 10 X PCR buffer (AB-gene products, Epsom, UK), 1.875 μL of MgCl2 (25 mmol·L−1) (AB-gene products, Epsom, UK), 0.5 μL of each dNTP (100 mmol·L−1) (dATP, dGTP, dCTP and dTTP) (AB-gene products, Epsom, UK) and 0.2 μL of 5 U·μL−1 of Thermus aquaticus (Taq) DNA polymerase (AB-gene products, Epsom, UK) [14]. The volume was brought up to 25 μL by adding sterile double distilled water. The mixture was placed in a thermocycler, Icycler (Bio-Rad, Hercules, California, USA). A negative control (no DNA template) and a positive control of B. melitensis DNA template, obtained from the American Type Culture Collection via the American University of Beirut Medical Center, Beirut, Lebanon, were included in every PCR assay. The cycles used for the amplification of the targeted BCSP-31 are summarized in Table II [22].

Table II.

Applied PCR cycles for the detection of genus- and species-specific Brucella and differentiation between vaccine and field strains.

For real-time PCR, a typical 25 μL reaction contained 0.5 μL of 200 nmol·L−1 of each primer, 2 μL of 50 ng·μL−1 of DNA template and 12.5 μL of 1 X IQ SYBR Green Supermix (100 mmol·L−1 KCl, 40 mmol·L−1 Tris-HCl, pH 8.4, 0.4 mmol·L−1 of each dNTP (dATP, dCTP, dGTP and dTTP), 50 U·mL−1 Taq DNA polymerase, 6 mmol·L−1 MgCl2, SYBR Green I, 20 nmol·L−1 fluorescein and stabilizers) (Bio-Rad, Hercules, California, USA). The volume was brought up to 25 μL by adding sterile double distilled water. The above mixtures were loaded into the wells of a 96-well plate and amplification was performed using a thermocycler (Bio-Rad, Hercules, California, USA). The amplification procedure is summarized in Table II [19].

The same standard PCR assay, used for the genus-specific identification, was performed for the amplification of the wboA gene. Table II also shows the applied cycles used for the differentiation between field and vaccine strains [24]. All the reactions (in both standard and real-time PCR) were terminated after 1 h incubation at 4 °C.

2.7. Agarose gel electrophoresis

Ten-microliter aliquot of each of the PCR products was mixed with 2 μL of 6 X loading dye (Bio-Rad, Hercules, California, USA). The PCR products were electrophoresed on 1% agarose gel at 90 V for 90 min. An EZ load 100 bp ruler (Bio-Rad, Hercules, California, USA) was used as a DNA ladder. After the run was completed, the bands were visualized under UV light and photographed.

2.8. Antimicrobial susceptibility testing

PCR-confirmed Brucella isolates were tested for their susceptibility to different antimicrobials, using the disk diffusion method as set by the National Committee for Clinical Laboratory Standards [2, 17]. The same protocol used in Harakeh et al. [12] was applied here for the antimicrobial susceptibility testing of Brucella.

The following antimicrobial disks, obtained from BioMerieux (Craponne, France), were used: Doxycycline (30 mcg), Streptomycin (10 mcg), Gentamicin (10 mcg), Tetracycline (30 mcg), Rifampicin (30 mcg), Ciprofloxacin (5 mcg), Ceftriaxone (30 mcg) and Trimethoprim-sulfamethoxazole (1.25 + 23.75 mcg) [1].


3.1. Levels of contamination with suspected Brucella and identification of Brucella species using conventional and molecular characterization methods

The levels of contamination with suspected Brucella species grown under either aerobic or microaerophilic conditions were highest in Shankleesh (16.7%), followed by Baladi cheese (13.3%) and Kishk (4.8%). It is documented that the presence of any Brucella organism in food products is unacceptable and can result in health-related problems [3, 11]. Based on this, about 13.3% of Baladi cheese, 16.7% of Shankleesh and 4.8% of Kishk samples were considered unacceptable for human consumption.

The suspected Brucella colonies (n = 110) displaying translucent, white and mucoid appearance were Gram stained. All the suspected isolates were Gram-negative coccobacilli. Only 8 out of the 110 were found to be oxidase positive by showing a light to dark blue color and urease positive by giving a pink color. Based on the data, the eight colonies could be B. melitensis, B. abortus, B. suis or B. canis.

For further characterization, the eight isolates were analyzed by PCR for the BCSP-31 gene using the primer pair BRU-UP and BRU-LOW. Based on the PCR data, it was found that 6 out of the 8 suspected isolates (75%) belonged to Brucella species with a characteristic band at ~ 443 bp. Real-time PCR was performed on the confirmed isolates in order to determine the different species of Brucella. The same forward primer was used in all the PCRs along with the three selected respective reverse primers specific for B. melitensis, B. abortus and B. suis. Only positive isolates with the B. abortus primer pair showed an increase in fluorescence, thus indicating amplification. The results indicated that all six isolates were B. abortus strains showing a specific PCR product of about 113 bp on agarose gel (Fig. 1). To determine whether the confirmed B. abortus isolates were RB51 vaccine or field B. abortus strains, standard PCR was used. The results indicated that all B. abortus isolates were field and not RB51 strains showing a 400 bp and not a 1300 bp fragment as is the case in vaccine strains [24]. Based on the PCR data, B. abortus was detected in approximately 4% of Baladi cheese, 6% of Shankleesh and 2% of Kishk samples, respectively. Such levels could be due to the absence of eradication of brucellosis in cows in Lebanon.

thumbnail Figure 1.

The electrophoretic profile of the real-time PCR products with the primer pair used for the detection of B. abortus, except for the positive strain. L: DNA ladder (EZ load 100 bp ruler); 1: B. melitensis positive strain; 2–7: DNA of suspected Brucella colonies among which two were isolated from cheese samples (Lanes: 3 and 6 (grown under microaerophilic conditions)), two from Shankleesh (Lanes: 2 (grown under microaerophilic conditions) and 5) and two from Kishk samples (Lanes: 4 and 7); 8: negative control.

These percentages of positive samples could be due to poor sanitary standards related to several factors. These factors involve direct contamination from animals via intra-mammary secretions or via fecal contamination of the udder, usage of same milking machine on many cows without frequent and proper cleaning, usage of non-cleaned milk bulk tanks, storage of milk at inappropriate temperatures and improper handling and transportation of milk. In addition to that, lack of hygienic practices during the processing of these products may also increase the contamination levels.

3.2. Antimicrobial susceptibility of B. abortus isolates

Brucella abortus isolates (n = 6) were resistant to at least one of the tested antimicrobials. High resistance (n = 4) was noted against Streptomycin and Ciprofloxacin, while 3 out of 6 isolates showed resistance to Gentamicin. Lower resistance was seen in response to Rifampicin, Tetracycline and Trimethoprim-sulfamethoxazole. High susceptibility was observed against Ceftriaxone and Doxycycline (Fig. 2). It is important to mention that these data are preliminary due to the low number of isolates. More future samples need to be collected and more isolates will be tested for their antimicrobial susceptibility. However, such findings are alarming and indicative of potential emergence of resistance strains of Brucella to antimicrobials. This emergence of antibiotic-resistant strains should be of great concern to the public, especially dairy producers, their families and employees because this organism is resistant to antimicrobials that are commonly used in medical treatment of human beings and in veterinary practices. The emergence of resistant bacterial strains might be attributed to the indiscriminate and uncontrolled use of antimicrobials to control diseases in infected herds of Lebanon.

thumbnail Figure 2.

Antimicrobial resistance patterns of the six B. abortus isolates. aCRO = Ceftriaxone; SXT = Trimethoprim-sulfamethoxazole; TE = Tetracycline; GM = Gentamicin; S = Streptomycin; D = Doxycycline; RA = Rifampicin; and CIP = Ciprofloxacin.

As stated in the literature, this resistance could be due to various mutations in chromosomal genes and not plasmid mediated [2, 14]. Moreover, Gram-negative bacteria have the ability to acquire resistance to a wide range of antimicrobials through the activation of drug efflux pumps. One type of efflux pump, the Resistance Nodulation Division (RND), is responsible for resistance phenotype observed in many bacterial species against a wide range of antimicrobials such as Quinolones, Tetracycline, Chloramphenicol, Streptomycin, Ampicillin, Rifampicin and others. A recent study conducted by Fernando et al. [10] has proved the involvement of two RND systems in mediating antimicrobial resistance in B. suis. Further studies are required to prove the role of such mechanism in the antimicrobial drug resistance detected in our samples [7, 10].


The results of this study provide an important baseline for the contamination status of Lebanese dairy-based food products by B. abortus and the patterns of its resistance to commonly used antimicrobials. The presence of multi-drug resistance strains is alarming. Obviously, the implementation of quality assurance programs such as HACCP in the preparation and processing of these foods and the control of usage of antimicrobial agents would help in reducing the risks of infections and the emergence of drug-resistant bacteria.

In addition, public education is required to increase people awareness to the dangers associated with the consumption of ready-to-eat foods that are not cooked or heated enough including unpasteurized milk, especially if consumers are immunocompromised people such as pregnant women, elderly or persons on immunosuppressive drug therapy. Moreover, additional research is required to better understand the mechanisms involved in the spread of antimicrobial resistance among environmental bacterial isolates and to determine the factors and reasons behind food contamination.


This investigation received technical and financial support from the Joint WHO Eastern Mediterranean Region (EMRO), Division of Communicable Diseases (TDR): The EMRO/TDR Small Grants Scheme for Operational Research in Tropical and other Communicable Diseases.


  1. Al Dahouk S., Tomaso H., Nockler K., Neubauer H., Frangoulidis D., Laboratory-based diagnosis of Brucellosis – a review of the literature, Clin. Lab. 40 (2003) 487–505. (In the text)
  2. Anon J.B., Brucellosis associated with unpasteurized milk products abroad, Commun. Dis. Rep. CDR Wkly. 5 (1995) 151. [PubMed] (In the text)
  3. Bricker B.J., PCR as a diagnostic tool for brucellosis, Vet. Microbiol. 90 (2002) 435–446. [CrossRef] [PubMed] (In the text)
  4. Bricker B.J., Halling S.M., Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR, J. Clin. Microbiol. 32 (1994) 2660–2666. [PubMed] (In the text)
  5. Center for Disease Control and Prevention (CDC), Basic Laboratory protocols for the presumptive identification of Brucella species, 2001. (In the text)
  6. De Buyser M., Dufour B., Maire M., Lafarge V., Implication of milk and milk products in food-borne diseases in France and in different industrialized countries, Int. J. Food Microbiol. 67 (2004) 1–17. [CrossRef] [PubMed] (In the text)
  7. Diana M.P., Fernando A.M., Julia V.S., Juan M.S., Victoria D., Pablo B., Eleonora C., Silvio L.C., Angeles Z., The TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence, Infect. Immun. 75 (2007) 379–389. [CrossRef] [PubMed] (In the text)
  8. Downes F.P., Ito K., Compendium of Methods for the Microbiological Examination of Foods, 4th edn., American Public Health Association, Washington, 2001. (In the text)
  9. ESUMOPH, Epidemiology surveillance unit of the Ministry of public health, 2005, (In the text)
  10. Fernando A.M., Diana M.P., Mariela C.C., Silvio L.C., David O., Angeles Z., Interplay between two RND systems mediating antimicrobial resistance in Brucella suis, J. Bacteriol. 191 (2009) 2530–2540. [CrossRef] [PubMed] (In the text)
  11. Gilbert R.J., De Louvois J., Donovan T., Little C., Nye K., Ribeiro C.D., Richards J., Roberts D., Bolton F., Guidelines for the microbiological quality of some ready-to-eat foods sampled at the point of sale, Commun. Dis. Public Health 3 (2000) 163–167. [PubMed] (In the text)
  12. Harakeh S., Saleh I., Zouhairi O., Baydoun E., Barbour E., Alwan N., Antimicrobial resistance of Listeria monocytogenes isolated from dairy-based food products, Sci. Total Environ. 408 (2009) 4022–4027. (In the text)
  13. Harakeh S., Yassine H., El Fadel M., Antimicrobial-resistance patterns of Escherichia coli and Salmonella strains in the aquatic Lebanese environments, Environ. Pollut. 143 (2006) 269–277. [CrossRef] [PubMed] (In the text)
  14. Hayes M.C., Ralyea R.D., Murphy S.C., Carey N.R., Scarlett J.M., Boor K.J., Identification and characterization of elevated microbial counts in bulk tank milk, J. Dairy Sci. 84 (2001) 292–298. [CrossRef] [PubMed] (In the text)
  15. Horwitz W., Official Methods of Analysis of AOAC International, 17th edn., AOAC International, Gaithersburg, 2000. (In the text)
  16. Leal-Klevezas D.S., Martinez-Vazquez I.O., Lopez-Merino A., Martinez Soriano J.P., Single-step PCR for detection of Brucella spp. from blood and milk of infected animals, J. Clin. Microbiol. 33 (1995) 3087–3090. [PubMed] (In the text)
  17. National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial disk susceptibility tests, Approved Standard, NCCLS Document M2-A6, 6th edn., Wayne, USA, 2004. (In the text)
  18. Ouahrani-Bettache S., Soubrier M., Liautard J., IS6501-anchored PCR for the detection and identification of Brucella species and strains, J. Appl. Bacteriol. 81 (1996) 154–160. [PubMed] (In the text)
  19. Redkar R., Rose S., Del Vecchio V., Real-time detection of Brucella abortus, Brucella melitensis and Brucella suis , Mol. Cell. Probes 15 (2001) 43–52. [CrossRef] [PubMed] (In the text)
  20. Saleh I., Zouhairi O., Alwan N., Hawi A., Barbour E., Harakeh S., Antimicrobial resistance and pathogenicity of Escherichia coli isolated from common dairy products in the Lebanon, Ann. Trop. Med. Parasitol. 103 (2009) 39–52. [CrossRef] [PubMed] (In the text)
  21. Schelling E., Diguimbaye C., Daoud S., Nicolet J., Boerlin P., Tanner M., Zinsstag J., Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad, Prev. Vet. Med. 61 (2003) 279–293. [CrossRef] [PubMed] (In the text)
  22. Tantillo G., Di Pinto A., Vergara A., Bounavoglia C., Polymerase chain reaction for the direct detection of Brucella spp. in milk and cheese, J. Food Prot. 64 (2001) 164–167. [PubMed] (In the text)
  23. Thakur S.D., Kumar R., Thapliyal D.C., Human Brucellosis: review of an under-diagnosed animal transmitted disease, J. Commun. Dis. 34 (2002) 287–301. [PubMed] (In the text)
  24. Vemulapalli R., McQuiston J., Schurig G., Sriranganathan N., Halling S., Boyle S., Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains, Clin. Diagn. Lab. Immunol. 6 (1999) 760–764. [PubMed] (In the text)
  25. Wallach J., Samartino L., Efron A., Baldi P., Human infection by Brucella melitensis: an outbreak attributed to contact with infected goats, FEMS Immunol. Med. Microbiol. 19 (1998) 315–321. (In the text)

All Tables

Table I.

Number of selected communes according to population size and the number of samples that should be collected in each trip.

Table II.

Applied PCR cycles for the detection of genus- and species-specific Brucella and differentiation between vaccine and field strains.

All Figures

thumbnail Figure 1.

The electrophoretic profile of the real-time PCR products with the primer pair used for the detection of B. abortus, except for the positive strain. L: DNA ladder (EZ load 100 bp ruler); 1: B. melitensis positive strain; 2–7: DNA of suspected Brucella colonies among which two were isolated from cheese samples (Lanes: 3 and 6 (grown under microaerophilic conditions)), two from Shankleesh (Lanes: 2 (grown under microaerophilic conditions) and 5) and two from Kishk samples (Lanes: 4 and 7); 8: negative control.

In the text
thumbnail Figure 2.

Antimicrobial resistance patterns of the six B. abortus isolates. aCRO = Ceftriaxone; SXT = Trimethoprim-sulfamethoxazole; TE = Tetracycline; GM = Gentamicin; S = Streptomycin; D = Doxycycline; RA = Rifampicin; and CIP = Ciprofloxacin.

In the text